Orchard Therapeutics Announces That OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agency
London, UK, 22 August, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company developing transformative gene therapies…